Christoph Saal;Tobias Schlueter;Michael Maiwald;Ulrich Emde;Kai Schiemann
发明人:
Kai Schiemann,Ulrich Emde,Tobias Schlueter,Christoph Saal,Michael Maiwald
申请号：
US12305524
公开号：
US08198452B2
申请日:
2007.05.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula Iwherein R1, R2, R3, R6, R7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer.
